Xinsheng Peng (Qiji Li)

Publication Activity (10 Years)

Years Active: 2017-2019
Publications (10 Years): 3

Top Topics

Prostate Cancer

Radical Prostatectomy

Signaling Pathway

Bone Regeneration

Top Venues

Journal of experimental & clinical cancer research : CR

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Qing Yang, Chuandong Lang, Zhengquan Wu, Yuhu Dai, Shaofu He, Wei Guo, Shuai Huang, Hong Du, Dong Ren, Xinsheng Peng
MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway. Journal of experimental & clinical cancer research : CR 38 (1) (2019)
Liping Ye, Chuyong Lin, Xi Wang, Xinsheng Peng, Yue Li, Meng Wang, Zekun Zhao, Xianqiu Wu, Dongni Shi, Yunyun Xiao, Liangliang Ren, Yunting Jian, Meisongzhu Yang, Ruizhang Ou, Guangzheng Deng, Ying Ouyang, Xiangfu Chen, Jun Li, Libing Song
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer. EMBO molecular medicine 11 (12) (2019)
Qiji Li, Liping Ye, Wei Guo, Min Wang, Shuai Huang, Xinsheng Peng
PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway. Journal of experimental & clinical cancer research : CR 36 (1) (2017)